Abstract

You have accessJournal of UrologyInfertility: Therapy II (PD58)1 Apr 2020PD58-06 WHAT IS THE PREDICTIVE VALUE OF A SPERMATIC CORD BLOCK PRIOR TO MICROSURGICAL DENERVATION OF THE SPERMATIC CORD? Sijo Parekattil*, Ahmet Gudeloglu, Onuralp Ergun, Mohammed Etafy, Nahomy Calixte, Jamin Brahmbhatt, and Richard Mendelson Sijo Parekattil*Sijo Parekattil* More articles by this author , Ahmet GudelogluAhmet Gudeloglu More articles by this author , Onuralp ErgunOnuralp Ergun More articles by this author , Mohammed EtafyMohammed Etafy More articles by this author , Nahomy CalixteNahomy Calixte More articles by this author , Jamin BrahmbhattJamin Brahmbhatt More articles by this author , and Richard MendelsonRichard Mendelson More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000968.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Microsurgical denervation of the spermatic cord (MDSC) has been shown to be a treatment option for men with intractable orchialgia/scrotal content pain. The standard of care is to perform a spermatic cord block to assess if there is any temporary relief in the pain prior to performing MDSC. This study assesses the predictive value of a spermatic cord block (SCB) with local anesthetic in determining post-MDSC outcomes. METHODS: A retrospective review of 1261 MDSC cases (1112 patients, 149 bilateral cases) from October 2008 to July 2019 was performed. An analysis of how the patients who had temporary relief in their pain (greater than 50% reduction) after a spermatic cord block correlated to their final outcome after MDSC was performed. The outcome after MDSC was graded as complete relief (CR) in pain, greater than 50% reduction in pain (PR) or no response (NR), defined as <50% reduction in pain. This outcome was based on preop and post-op measurements of pain using a validated quality of life metric (PIQ-6) and the visual analogue pain score (VAS). RESULTS: The positive predictive value (PPV) of a patient having a response to SCB and then achieving CR or PR was 78%, and achieving CR alone was 41%. The negative predictive value (NPV) of a patient who did not have any relief with SCB, and then achieving NR after MDSC was 57%. CONCLUSIONS: This study illustrates that if a patient has no response to SCB, MDSC is less likely to help reduce pain in these patients. However, a positive response to SCB confers a high likelihood of significant reduction in pain after MDSC. Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1202-e1202 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sijo Parekattil* More articles by this author Ahmet Gudeloglu More articles by this author Onuralp Ergun More articles by this author Mohammed Etafy More articles by this author Nahomy Calixte More articles by this author Jamin Brahmbhatt More articles by this author Richard Mendelson More articles by this author Expand All Advertisement PDF downloadLoading ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.